DCT
1:21-cv-00425
Astellas Pharma Inc v. Aurobindo Pharma Ltd
Log In
Overview
Analysis
General
Parties
Attorneys
Patents
Products
Related Cases
Dockets
General
Filed
03/24/21
Cause of Action
Patent Infringement
Sector
Biotech
Status
Closed (07/26/23)
Patent Owner
NPE
(L)
Source
PACER
Nature of Suit
835 ANDA
Appeals
23-2032
,
23-2089
Court
D. Delaware
Judge
Period
PO Win Rate
Joseph F. Bataillon
03/31/21 - 05/04/26
52%
Magistrate
Christopher J. Burke, Liles C. Burke
Plaintiff
Party
Name
Ratings
Astellas Pharma US Inc
NPE
L3
A
Astellas Pharma Global Development Inc
NPE
L3
A
Astellas Ireland Co Ltd
NPE
L3
A
Show all (1 more)
Attorney
Name
Ratings
McCarter & English LLP
L4
A
Daniel M. Silver
L5
A
Alexandra M. Joyce
L4
A
Hogan Lovells US LLP
L3
B
Celine J. Crowson
L5
A
Jason A. Leonard
L5
A
Simon D. Roberts
L5
B
Vincent Li
L4
D
Nitya Anand
L3
E
Chika Seidel
L3
--
--
Attorney at Law
Local
--
--
--
J. Leonard
--
--
--
Show all (2 more)
Defendant
Party
Name
Ratings
Aurobindo Pharma USA Inc
L5
E
Actavis LLC
L5
E
Actavis Elizabeth LLC
L5
E
Teva Pharmaceuticals USA Inc
L5
E
Lupin Pharmaceuticals Inc
L5
E
Lupin Ltd
L5
E
Aurolife Pharma LLC
L5
E
Zydus Pharmaceuticals USA Inc
L4
E
Cadila Healthcare Ltd
L4
E
Show all (7 more)
Attorney
Name
Ratings
Young Conaway Stargatt & Taylor LLP
L2
C
Pilar G. Kraman
--
--
--
Morris James LLP
L1
D
Cortlan Hitch
--
--
--
Shaw Keller LLP
L1
E
Andrew Russell
--
--
--
Phillips Goldman McLaughlin & Hall PA
L1
E
John C. Phillips, Jr.
--
--
--
Megan C. Haney
--
--
--
Show all (-1 more)